List of ZONTAL Customers
ZONTAL
1234 North 900 East, Suite 200,
Provo, 33324, UT,
United States
Provo, 33324, UT,
United States
1 385-375-2389
Professional Services
80
$9M
Since 2010, our global team of researchers has been studying ZONTAL customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased ZONTAL for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using ZONTAL for Laboratory Management include: Regeneron Pharmaceuticals, a United States based Life Sciences organisation with 15182 employees and revenues of $142.02 billion, Johnson & Johnson, a United States based Life Sciences organisation with 138100 employees and revenues of $88.82 billion, AstraZeneca, a United Kingdom based Life Sciences organisation with 94300 employees and revenues of $73.98 billion, Merck, a United States based Life Sciences organisation with 73000 employees and revenues of $64.17 billion, Bayer, a Germany based Life Sciences organisation with 92815 employees and revenues of $55.47 billion and many others.
Contact us if you need a completed and verified list of companies using ZONTAL, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The ZONTAL customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AstraZeneca | Life Sciences | 94300 | $74.0B | United Kingdom | ZONTAL | ZONTAL | Laboratory Management | 2023 | n/a |
In 2023, AstraZeneca deployed ZONTAL as its Scientific Data Management Platform for a UK Laboratory Management implementation. The programme established an SDMS data model rooted in FAIR data principles, orienting metadata strategy and structured data capture for R&D laboratory outputs.
The ZONTAL implementation concentrated on core Laboratory Management capabilities, including standardized metadata capture, a governed scientific data model, data ingestion and indexing, cataloging for discovery, and access controls and audit trails aligned with research compliance requirements. Configuration work focused on mapping required metadata fields and taxonomies to ensure data items stored in ZONTAL carried the contextual metadata necessary for reuse and provenance.
Operational scope covered United Kingdom R&D laboratory teams, with delivery activities that included workshops to document As is and To be processes, capture business requirements, and specify associated metadata for datasets to be retained in ZONTAL. The project team included business analysts and technical engineers working under a central project manager to align laboratory operations, data stewardship, and scientific workflows with the new SDMS.
Project governance was run using agile practices, with daily scrums, backlog grooming, and sprint planning to drive incremental configuration and demos. Rollout activities emphasized training, stakeholder communications, and business change management to embed ZONTAL into lab workflows, while requirement capture and regular demonstrations were used to validate configuration against R&D needs.
|
|
|
AstraZeneca Sweden | Life Sciences | 8000 | $1.7B | Sweden | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
In 2020, AstraZeneca Sweden implemented ZONTAL as its Laboratory Management platform for R&D labs. The ZONTAL deployment formed a core element of an enterprise lab data initiative centered on an Accessible Lab Data Platform.
The implementation was integrated into an Accessible Lab Data Platform and a data lake hosted in AWS cloud, supporting more than 2500 instruments and roughly 6000 scientists globally. ZONTAL was implemented with explicit data pipelines, data engineering and analytical capabilities, and the project included integration with Revvity Signals ELN to streamline laboratory records and experiment data flows.
Governance and architecture were formalized through reference architecture and design patterns, data stewardship processes, and compliance checks aligned to ALCOA plus principles, FAIR data principles, ISO27001 and SAFe architecture principles. The platform was qualified for business use with the necessary IT artefacts, and the implementation targeted R&D laboratory data management, lab informatics standardization and enterprise data governance.
|
 |
Bayer | Life Sciences | 92815 | $55.5B | Germany | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
In 2020, Bayer deployed ZONTAL as its Laboratory Management solution to standardize laboratory operations and quality workflows across its life sciences organization. The deployment targeted laboratory operations and quality assurance functions, aligning ZONTAL with compliance and sample lifecycle management requirements within Bayer’s research and testing environments.
ZONTAL was configured to provide core Laboratory Management capabilities, including sample lifecycle tracking, instrument and inventory management, workflow orchestration, electronic audit trails, and compliance reporting. The ZONTAL implementation emphasized configurable workflows and role based access controls consistent with laboratory informatics practices, enabling controlled data capture and traceability.
Auditors evaluated the implementation in the context of Bayer’s broader IT and compliance landscape and reported that ZONTAL demonstrated effective interoperability with existing processes and governance models, without naming specific integrations. The review covered operational controls and system maturity across laboratory and quality functions and confirmed alignment with regulatory readiness expectations.
The audit concluded with no critical or major findings, stating that ZONTAL was fully compliant with all items reviewed. Auditors expressed a high degree of confidence in the maturity of Bayer’s systems and their ability to collaborate within complex IT and compliance landscapes, noting well-established services and operational governance around the ZONTAL Laboratory Management deployment.
|
 |
Bruker BioSpin | Life Sciences | 1300 | $270M | Germany | ZONTAL | ZONTAL | Laboratory Management | 2023 | n/a |
In 2023, Bruker BioSpin implemented ZONTAL as a Laboratory Management application to standardize laboratory operations and scientific data handling across its Germany-based life sciences organization, which has approximately 1,300 employees. The deployment positioned ZONTAL as the primary Laboratory Management platform supporting R&D and manufacturing scientific data management workflows within Bruker BioSpin.
The ZONTAL implementation focused on core Laboratory Management capabilities, including sample lifecycle management, inventory and reagent tracking, experiment and protocol orchestration, electronic lab notebook style experiment capture, configurable workflow templates, and audit trail and compliance controls. Configuration emphasized role-based access and template-driven SOP enforcement to align laboratory procedures with internal quality and governance requirements.
Operational design concentrated on capturing structured experiment data and instrument outputs, and on enabling laboratory workflow orchestration across research and manufacturing laboratory functions. The implementation connected ZONTAL data models to Bruker BioSpin laboratory processes, supporting standardized records for experiments, reagents, and batch-related laboratory activities without specifying external system vendors.
Governance for ZONTAL included defined user roles, approval gates, and record retention rules to support regulatory and internal audit needs, alongside staged rollout and training for laboratory teams. Change management centered on embedding new workflow orchestration and data governance practices into daily lab operations, aligning Laboratory Management capability with Bruker BioSpin business functions in R&D and manufacturing.
|
 |
Chiesi Farmaceutici | Life Sciences | 6389 | $2.5B | Italy | ZONTAL | ZONTAL | Laboratory Management | 2018 | n/a |
In 2018, Chiesi Farmaceutici implemented ZONTAL as its Laboratory Management application. The deployment established ZONTAL as the primary platform for laboratory operations, aligning sample lifecycle management and laboratory data capture with pharmaceutical R&D and quality control functions.
Configuration work centered on core Laboratory Management capabilities including sample and batch tracking, workflow orchestration, electronic results capture and reporting, and regulatory audit trails. Automation of test scheduling and role based access controls were configured to support standardized laboratory procedures and instrument-driven workflows.
Integrations emphasized instrument connectivity and consolidation of laboratory datasets, with interfaces planned to feed quality systems and laboratory reporting processes. Operational coverage focused on Chiesi laboratory groups responsible for analytical testing and quality oversight, consolidating laboratory data flows under ZONTAL Laboratory Management.
Governance was organized through ZONTAL Professional Services acting in a global program manager capacity, coordinating configuration, validation scripts, user acceptance testing, and release governance tied to standard operating procedures. The implementation formalized laboratory workflow ownership and change control processes within Chiesi Farmaceutici for ongoing system operations.
|
 |
|
Life Sciences | 1309 | $513M | Belgium | ZONTAL | ZONTAL | Laboratory Management | 2021 | n/a |
|
|
|
|
Life Sciences | 2635 | $2.3B | Denmark | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
|
|
|
|
Life Sciences | 138100 | $88.8B | United States | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
|
|
|
|
Oil, Gas and Chemicals | 11685 | $16.7B | United Kingdom | ZONTAL | ZONTAL | Laboratory Management | 2018 | n/a |
|
|
|
|
Life Sciences | 73000 | $64.2B | United States | ZONTAL | ZONTAL | Laboratory Management | 2020 | n/a |
|
Showing 1 to 10 of 14 entries
Buyer Intent: Companies Evaluating ZONTAL
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating ZONTAL. Gain ongoing access to real-time prospects and uncover hidden opportunities.
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD ZONTAL Coverage
ZONTAL is a Laboratory Management solution from ZONTAL.
Companies worldwide use ZONTAL, from small firms to large enterprises across 21+ industries.
Organizations such as Regeneron Pharmaceuticals, Johnson & Johnson, AstraZeneca, Merck and Bayer are recorded users of
ZONTAL for Laboratory Management.
Companies using ZONTAL are most concentrated in Life Sciences, with adoption spanning over 21 industries.
Companies using ZONTAL are most concentrated in United States, United Kingdom and Germany, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of ZONTAL across Americas, EMEA, and APAC.
Companies using ZONTAL range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 7.14%, large organizations with 1,001-10,000 employees - 35.71%, and global enterprises with 10,000+ employees - 57.14%.
Customers of ZONTAL include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified ZONTAL customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Laboratory Management.